PURPOSE OF REVIEW: It has been 10 years since pathological high-frequency oscillations (pHFOs) were described in the brain of epileptic animals and patients. This review summarizes progress in research on mechanisms of their generation and potential clinical applications over that period. RECENT FINDINGS: Initially, pHFOs were recorded with microelectrodes in the hippocampus of rodents and patients with mesial temporal lobe epilepsy (MTLE), but recently pHFOs have also been recorded with clinical depth and grid electrodes in multiple brain areas including the hippocampus and neocortex of patients with different types of epilepsy. One hypothesis is that pHFOs reflect fields of hypersynchronized action potentials (bursts of population spikes) within small discrete neuronal clusters responsible for seizure generation. Studies suggest that pHFOs can be used as a reliable biomarker for epileptogenesis, epileptogenicity, and the delineation of the epileptogenic region. SUMMARY: Recording of pHFOs with clinical electrodes provides a means for further investigation of their functional role in the epileptic brain and as a potential biomarker of epileptogenesis and epileptogenicity and for presurgical mapping.
PURPOSE OF REVIEW: It has been 10 years since pathological high-frequency oscillations (pHFOs) were described in the brain of epileptic animals and patients. This review summarizes progress in research on mechanisms of their generation and potential clinical applications over that period. RECENT FINDINGS: Initially, pHFOs were recorded with microelectrodes in the hippocampus of rodents and patients with mesial temporal lobe epilepsy (MTLE), but recently pHFOs have also been recorded with clinical depth and grid electrodes in multiple brain areas including the hippocampus and neocortex of patients with different types of epilepsy. One hypothesis is that pHFOs reflect fields of hypersynchronized action potentials (bursts of population spikes) within small discrete neuronal clusters responsible for seizure generation. Studies suggest that pHFOs can be used as a reliable biomarker for epileptogenesis, epileptogenicity, and the delineation of the epileptogenic region. SUMMARY: Recording of pHFOs with clinical electrodes provides a means for further investigation of their functional role in the epileptic brain and as a potential biomarker of epileptogenesis and epileptogenicity and for presurgical mapping.
Authors: Benoît Crépon; Vincent Navarro; Dominique Hasboun; Stéphane Clemenceau; Jacques Martinerie; Michel Baulac; Claude Adam; Michel Le Van Quyen Journal: Brain Date: 2009-11-17 Impact factor: 13.501
Authors: Houman Khosravani; Nikhil Mehrotra; Michael Rigby; Walter J Hader; C Robert Pinnegar; Neelan Pillay; Samuel Wiebe; Paolo Federico Journal: Epilepsia Date: 2008-08-20 Impact factor: 5.864
Authors: Jennifer A Ogren; Charles L Wilson; Anatol Bragin; Jack J Lin; Noriko Salamon; Rebecca A Dutton; Eileen Luders; Tony A Fields; Itzhak Fried; Arthur W Toga; Paul M Thompson; Jerome Engel; Richard J Staba Journal: Ann Neurol Date: 2009-12 Impact factor: 10.422
Authors: William S Anderson; Feraz Azhar; Pawel Kudela; Gregory K Bergey; Piotr J Franaszczuk Journal: Epilepsy Res Date: 2011-12-12 Impact factor: 3.045
Authors: Syed Faraz Kazim; Joon Ho Seo; Riccardo Bianchi; Chloe S Larson; Abhijeet Sharma; Robert K S Wong; Kirill Y Gorbachev; Ana C Pereira Journal: eNeuro Date: 2021-04-23